Form 8-K - Current report:
SEC Accession No. 0000950170-25-092168
Filing Date
2025-07-01
Accepted
2025-07-01 16:00:27
Documents
10
Period of Report
2025-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K cue-20250630.htm   iXBRL 8-K 70147
  Complete submission text file 0000950170-25-092168.txt   199104

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cue-20250630.xsd EX-101.SCH 44883
12 EXTRACTED XBRL INSTANCE DOCUMENT cue-20250630_htm.xml XML 4511
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 251096171
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)